Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07326748 · ClinicalTrials.gov registry record · NA

Lakota Family Acceptance Project

A NA study of Depression and Anxiety, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
28
Enrollment target
2
Study locations

NCT07326748: Recruiting NA study of Depression and Anxiety, sponsored by University of Michigan.

NCT07326748 is a NA study of Depression and Anxiety that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 28 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07326748, a NA study of Depression and Anxiety, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
28 participants
Enrollment target
2
Study locations

Study Summary

The goal of this open pilot trial (OPT) is to develop a Lakota-adapted Family Acceptance Project (LFAP) for Indigenous 2SLGBTQ+ youth and their caregivers. The OPT is specifically focused on acceptability, feasibility, and safety of programming and research protocols. The investigators will also examine pre- to post- changes on outcomes for the sole purposes of making sure scores on measures are changing in the hypothesized direction (e.g., depression scores are going from moderate to minimal as opposed to no change or depression scores increasing). Once enrolled in the study, participants complete a baseline survey. Then participants will engage in LFAP which is an 8-session group intervention; sessions will be scheduled once a week for eight weeks (at 2 hours per session). Participants will complete survey instruments before and immediately after the program sessions, in addition to post-program surveys and an exit interview.

Primary Outcome

Participant responses to items from the Suicidal Ideation Attributes Scale to measure suicide and life-threatening behavior in the past month. The 5-item scale includes likert response options ranging from 0 = Never to 10 = Always with higher scores indicating severity of suicidal ideation.

Conditions Studied

Depression Anxiety Drug Use Racial Disparities LGBTQ Minority Stress Teen Dating Violence Family Relationships Sexual Risk Reduction

Interventions

  • BEHAVIORAL Adapted Lakota Family Acceptance Program

Study Locations (2)

South Dakota

  • Wahwala Iyohlogya/Peaceful Means - Pine Ridge
  • University of Michigan/Rapid City - Rapid City

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2026-01-20
Est. Completion 2027-01-31
Phase NA
University of Michigan

1,327 total trials

What NCT07326748 shows while recruiting

NCT07326748 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower).

The record links to 9 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Adapted Lakota Family Acceptance Program is the first listed.

NCT07326748 reports a single indexed study location in South Dakota.

Frequently Asked Questions

What is clinical trial NCT07326748 about?

NCT07326748 is a clinical study titled "Lakota Family Acceptance Project". The goal of this open pilot trial (OPT) is to develop a Lakota-adapted Family Acceptance Project (LFAP) for Indigenous 2SLGBTQ+ youth and their caregivers. The OPT is specifically focused on acceptability, feasibility, and safety of programming and research protocols. The investigators will also exa...

What is the current status of trial NCT07326748?

This trial is currently recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2026-01-20. Estimated completion is 2027-01-31.

What conditions does trial NCT07326748 study?

This clinical trial studies the following conditions: Depression, Anxiety, Drug Use, Racial Disparities, LGBTQ.

What interventions are being tested in trial NCT07326748?

The interventions under investigation include: Adapted Lakota Family Acceptance Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT07326748?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07326748 being conducted?

This trial has 2 study locations across South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07326748's enrollment target sits among peer trials

28 582nd of 679 higher than 98 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

More recruiting context for NCT07326748

Source: ClinicalTrials.gov NCT07326748, the US trial registry maintained by the National Library of Medicine. NCT07326748 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.